Bal Pharma

quarterly
yearly
ParticularsMar '25Jun '25Sep '25Dec '25Mar '26
Revenue82.9666.5975.1488.0283.84
Expenses80.3766.3874.4386.2280.63
EBITDA8.726.786.859.8710.33
Operating Profit6.544.264.586.647.28
Profit Before Tax2.590.210.721.793.21
Net Profit5.420.210.721.793.60
Financial Ratios
Operating Profit Margin10.65%10.29%9.25%11.26%12.29%
Net Profit Margin6.63%0.30%0.96%2.03%4.27%
Earning Per Share (Diluted)3.400.130.451.122.26
Dividends Per Share0.000.000.000.000.00